Related Experiment Video
Updated: Jan 27, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from
Antongiulio Faggiano1, Silvana Di Maio2, Carmela Mocerino3
1Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. antongiulio.faggiano@uniroma1.it.
Purpose:
Many different treatments are suggested by guidelines to treat grade 1-2 (G1-G2) neuroendocrine tumors (NET). However, a precise therapeutic algorithm has not yet been established. This study aims at identifying and comparing the main therapeutic sequences in G1-G2 NET.
Methods:
A retrospective observational Italian multicenter study was designed to collect data on therapeutic sequences in NET. Median progression-free survival (PFS) was compared between therapeutic sequences, as well as the number and grade of side effects and the rate of dose reduction/treatment discontinuation.
Results:
Among 1182 patients with neuroendocrine neoplasia included in the ELIOS database, 131 G1-G2 gastroenteropancreatic, lung and unknown primary NET, unresectable or persistent/relapsing after surgery, treated with ≥2 systemic treatments, were included. Four main therapeutic sequences were identified in 99 patients: (A) somatostatin analogs (SSA) standard dose to SSA high dose (n = 36), (B) SSA to everolimus (n = 31), (C) SSA to chemotherapy (n = 17), (D) SSA to peptide receptor radionuclide therapy (PRRT) (n = 15). Median PFS of the second-line treatment was not reached in sequence A, 33 months in sequence B, 20 months in sequence C, 30 months in sequence D (p = 0.16). Both total number and severity of side effects were significantly higher in sequences B and C than A and D (p = 0.04), as well as the rate of dose reduction/discontinuation (p = 0.03).
Conclusions:
SSA followed by SSA high dose, everolimus, chemotherapy or PRRT represent the main therapeutic sequences in G1-G2 NET. Median PFS was not significantly different between sequences. However, the sequences with SSA high dose or PRRT seem to be better tolerated than sequences with everolimus or chemotherapy.
Insights
For grade 1-2 neuroendocrine tumors (NET), somatostatin analogs (SSA) followed by high-dose SSA or peptide receptor radionuclide therapy (PRRT) are well-tolerated treatment sequences. These approaches show comparable progression-free survival to everolimus or chemotherapy but with fewer side effects.
Area of Science:
- Oncology
- Endocrinology
- Medical treatment efficacy
Background:
- Guidelines suggest multiple treatments for grade 1-2 neuroendocrine tumors (G1-G2 NET).
- A definitive therapeutic algorithm for G1-G2 NET remains elusive.
- This study investigates established treatment sequences for G1-G2 NET.
Purpose of the Study:
- To identify and compare the primary therapeutic sequences used for G1-G2 NET.
- To evaluate treatment efficacy and safety profiles of different therapeutic sequences.
Main Methods:
- A retrospective, observational, multicenter study was conducted in Italy.
- Data from 131 patients with G1-G2 NET from the ELIOS database were analyzed.
- Progression-free survival (PFS), side effects, and treatment discontinuation rates were compared across four main therapeutic sequences.
Main Results:
- Four main sequences were identified: SSA to high-dose SSA (n=36), SSA to everolimus (n=31), SSA to chemotherapy (n=17), and SSA to PRRT (n=15).
- Median PFS did not significantly differ between sequences (p=0.16).
- Sequences involving everolimus or chemotherapy exhibited significantly higher rates of side effects and treatment discontinuation compared to high-dose SSA or PRRT (p=0.04 and p=0.03, respectively).
Conclusions:
- Somatostatin analogs (SSA) followed by high-dose SSA, everolimus, chemotherapy, or PRRT are the main therapeutic sequences for G1-G2 NET.
- While median PFS was similar across sequences, high-dose SSA and PRRT were better tolerated.
- These findings suggest that high-dose SSA or PRRT may be preferable second-line treatments due to improved tolerability.
Related Concept Videos
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
Techniques of therapeutic communication I: Active Listening, Sharing Observations, Validation, and Using Touch
Therapeutic communication is not the same as social interaction. Social interaction has no goal or purpose and consists of casual information sharing, whereas therapeutic communication has a plan or purpose for the conversation. Therapeutic...
Graded Potential
Graded potentials fall into two categories: depolarizing and hyperpolarizing. Depolarizing graded potentials typically occur when sodium (Na+) or...
Naturalistic Observations
Types of Aggregate Grading
Well-graded aggregates include a complete range of necessary size fractions that fit together to create a dense matrix with minimal voids, represented by a smooth, continuous gradation curve. This type of grading ensures good...

